Ecosystem
Beta Site
Search Results
574 items found for "Orphan GPCR"
- Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Raises $10 Million In Equity Financing
Read more at the source #DrGPCR #GPCR #IndustryNews
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Read more at the source #DrGPCR #GPCR #IndustryNews
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Read more at the source #DrGPCR #GPCR #IndustryNews
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
" Read more at the source #DrGPCR #GPCR #IndustryNews
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
Read more at the source #DrGPCR #GPCR #IndustryNews
- Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research
Peter joined Tectonic to help chart new territory in GPCR science. Read more at the source #DrGPCR #GPCR #IndustryNews
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
R ead more at the source #DrGPCR #GPCR #IndustryNews
- Learn more about Neurocrine Biosciences with their new video
Read more at the source #DrGPCR #GPCR #IndustryNews
- ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Novo Nordisk moves to strengthen obesity efforts
Re ad more at the source #DrGPCR #GPCR #IndustryNews
- Ermium Therapeutics has constituted its SAB
Therapeutics Announces the Formation of a Scientific Advisory Board comprising international leaders in GPCRs immunology, drug discovery and development for auto-immune diseases" Read more at the source #DrGPCR #GPCR
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
media at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST) the same day. " Read more at the source #DrGPCR #GPCR
- ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
Read more at the source #DrGPCR #GPCR #IndustryNews
- Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted (Québec, Canada; “UdM”), to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Naggie and Rajagopal Elected Members of American Society for Clinical Investigation
" Read more at the source #DrGPCR #GPCR #IndustryNews
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
Read more at the source #DrGPCR #GPCR #IndustryNews
- Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Drug Discovery Picks Up the Pace, Stays on Target
drug efficacy analyses, and toxicity studies; technologies that stabilize G protein–coupled receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
Read more at the source #DrGPCR #GPCR #IndustryNews
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
Read more at the source #DrGPCR #GPCR #IndustryNews
